Beware of Reversal of an Anticoagulated Patient with Factor IX in the Emergency Department: Case Report of a Medical-Legal Misadventure-Reference-Cited by-同舟云学术

Beware of Reversal of an Anticoagulated Patient with Factor IX in the Emergency Department: Case Report of a Medical-Legal Misadventure

Published:2020-01-24 Issue:1 Volume:4 Page:12-15
ISSN:2474-252X
Container-title:Clinical Practice and Cases in Emergency Medicine
language:
Short-container-title:

Author:

Gannon Steven¹,Bell David²,Jackmiczyk Kenneth²,Moore Gregory³

Affiliation:

1. Baylor University Medical Center, Pulmonary and Critical Care Medicine, Dallas, Texas

2. Maricopa Medical Center, Department of Emergency Medicine, Phoenix, Arizona; University of Arizona College of Medicine-Phoenix, Department of Emergency Medicine, Phoenix, Arizona

3. Mayo Clinic, Department of Emergency Medicine, Rochester, Minnesota

Abstract

In this article we present a case of a patient who received reversal of anticoagulation therapy with factor IX in violation of hospital guidelines. As a direct result, myocardial infarction and ischemic stroke occurred, leaving the patient neurologically debilitated. Factor IX is indicated in the setting of warfarin-induced, life-threatening bleeding. The patient’s care was provided by an intern with attending physician supervision. Delayed charting and questionable shared decision-making were present in the care. We discuss usage of factor IX, liability for supervision of physicians in training, and factors that can lead to plaintiff awards.

Publisher

Western Journal of Emergency Medicine

Subject

Emergency Nursing,Emergency Medicine

Reference15 articles.

1. Tripp vs The Arizona Board of Regents,,Case No. C20144811. (Superior Court of Arizona-Pima County)

2. Frontera JA, Gordon E, Zach V, et al. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage. Neurocrit Care. 2014;21(3):397-406.

3. Baker RI, Coughlin PB, Gallus AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust. 2004;181(9):492-7.

4. Holland L, Warkentin TE, Refaai M, et al. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion. 2009;49(6):1171-7.

5. Guyatt GH, Akl EA, Crowther M, et al. Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S-47.